Gabriel Ling's most recent trade in Oncology Institute Inc (The) was a trade of 46,296 Common Stock done . Disclosure was reported to the exchange on Nov. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology Institute Inc | Gabriel Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 46,296 | 296,502 | - | 0 | Common Stock | |
| Oncology Institute Inc | Gabriel Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 37,037 | 333,539 | - | 0 | Common Stock | |
| Oncology Institute Inc | Gabriel Ling | Director | Other type of transaction at price $ 0.00 per share. | 18 Nov 2025 | 141,149 | 250,206 | - | - | Common Stock | |
| Oncology Institute Inc | Gabriel Ling | Director | 22 Nov 2024 | 40,000 | 109,057 | - | 0 | Common stock | ||
| Oncology Institute Inc | Gabriel Ling | Director | 26 Dec 2023 | 40,000 | 69,057 | - | 0 | Common stock | ||
| Oncology Institute Inc | Gabriel Ling | Director | 17 Nov 2022 | 29,057 | 29,057 | - | 0 | Common Stock |